Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference31 articles.
1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009
2. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide;Sherriff;Br J Radiol,2013
3. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005
4. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype;Lim;Neuro Oncol,2007
5. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme;Nakagawa;Int J Radiat Oncol Biol Phys,1998
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Histopathologically confirmed radiation-induced damage of the brain – an in-depth analysis of radiation parameters and spatio-temporal occurrence;Radiation Oncology;2023-12-12
2. Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial;Journal of Neuro-Oncology;2023-07-15
3. 初発膠芽腫患者における光線力学療法後の再発形式;The Journal of Japan Society for Laser Surgery and Medicine;2023-07-15
4. Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study;The British Journal of Radiology;2023-06-01
5. Targeting the neural stem cells in subventricular zone for the treatment of glioblastoma: an update from preclinical evidence to clinical interventions;Stem Cell Research & Therapy;2023-05-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3